AP2S1
AP-2 complex subunit sigma
Also known as: AP2S1_HUMAN, CLAPS2, FBH3, FBHOk, HHC3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P53680
- Gene
- AP2S1
- Ensembl
- ENSG00000042753
- Chromosome
- 19
- Canonical length
- 142 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters
OverviewNCBI Gene
One of two major clathrin-associated adaptor complexes, AP-2, is a heterotetramer which is associated with the plasma membrane. This complex is composed of two large chains, a medium chain, and a small chain. This gene encodes the small chain of this complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>P53680|AP2S1
1 MIRFILIQNR AGKTRLAKWY MQFDDDEKQK LIEEVHAVVT VRDAKHTNFV EFRNFKIIYR
61 RYAGLYFCIC VDVNDNNLAY LEAIHNFVEV LNEYFHNVCE LDLVFNFYKV YTVVDEMFLA
121 GEIRETSQTK VLKQLLMLQS LELocalizationUniProt · AlphaFold · HPA
Whether an antibody against AP2S1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 209 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 209 nTPM
- cerebral cortex: 177 nTPM
- liver: 156 nTPM
- amygdala: 156 nTPM
- adrenal gland: 146 nTPM
- hippocampal formation: 139 nTPM
Single-cell type
- hofbauer cells: 1,390 nCPM
- esophageal apical cells: 1,224 nCPM
- esophageal suprabasal cells: 1,043 nCPM
- esophageal basal cells: 602 nCPM
- kupffer cells: 587 nCPM
- cytotrophoblasts: 492 nCPM
Immune cell
- myeloid DC: 718 nTPM
- intermediate monocyte: 710 nTPM
- total PBMC: 673 nTPM
- classical monocyte: 642 nTPM
- non-classical monocyte: 547 nTPM
- plasmacytoid DC: 433 nTPM
Brain region
- cerebral cortex: 119 nTPM
- basal ganglia: 114 nTPM
- hypothalamus: 113 nTPM
- hippocampal formation: 103 nTPM
- thalamus: 101 nTPM
- white matter: 101 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AP2S1.
Disease | AllUniProt
Conditions AP2S1 is implicated in, by any mechanism.
- Hypocalciuric hypercalcemia, familial 3 (HHC3) MIM:600740
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 142 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial hypocalciuric hypercalcemia 3
- AP2S1-related disorder
- Familial hyperparathyroidism or Hypocalciuric hypercalcaemia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0.79
- gnomAD missense Z
- 2.86
- DepMap mean gene effect
- -0.57
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- clathrin coat assembly
- clathrin-dependent endocytosis
- intracellular protein transport
- postsynaptic neurotransmitter receptor internalization
- regulation of endocytosis
- synaptic vesicle endocytosis
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AP2S1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AP2S1 as an antibody target. Whether an autoantibody or antibody against AP2S1 could matter depends on whether native AP2S1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AP2S1 is annotated at the cell surface, where native AP2S1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AP2S1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...